Security key
G7709Q104
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)
CUSIP: G7709Q104
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 424,966,351
- Total 13F shares
- 327,857,254
- Share change
- -14,283,438
- Total reported value
- $11,565,432,295
- Put/Call ratio
- 20%
- Reported price per share
- $35.28
- Number of holders
- 484
- Value change
- -$513,196,140
- Number of buys
- 292
- Number of sells
- 183
Security identity
Holder snapshot
Report period
Q3 2025
Institutions
484
Top holders
10
RPRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Royalty Pharma plc SEC filings
Royalty Pharma plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP G7709Q104
Recent filing periods:
Ownership snapshot
Top shareholders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Legorreta G. Pablo
13D/G signal
Legorreta G. Pablo
Evidence rows
50
Latest as of
31 Jul 2025
13D/G
13F
3/4/5
Lead comparable stake: 20%
13D/G row: Legorreta G. Pablo
Showing first 8 of 50 holder rows.
Open remaining rows
Rank 1 holder
Legorreta G. Pablo
13D/G
- Ownership
- 20%
- Position
- $3.37B
Rank 2 holder
MORGAN STANLEY
13F
13D/G
- Ownership
- 9.2%
- Position
- $1.68B
Rank 3 holder
FMR LLC
13F
13D/G
- Ownership
- 6.5%
- Position
- $1.45B
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Legorreta G. Pablo |
13D/G
|
20%
|
$3,372,819,557
103,112,796 shares
|
$0 | 16 May 2025 |
| MORGAN STANLEY |
13F
13D/G
Company
|
9.2%
from 13D/G
|
$1,679,145,924
46,604,103 shares
|
— | 30 Jun 2025 |
| FMR LLC |
13F
13D/G
Company
|
6.5%
from 13D/G
|
$1,454,092,272
40,357,821 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.7%
from 13D/G
|
$916,201,678
25,428,856 shares
|
— | 30 Jun 2025 |
| GENERAL ATLANTIC, L.P. |
13D/G
13F
Company
|
3.2%
|
$510,500,301
14,243,870 shares
|
$0 | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
2.5%
from 13D/G
|
$1,310,687,739
36,377,678 shares
|
— | 30 Jun 2025 |
| Henry A. Fernandez |
3/4/5
Director
|
0.03%
|
$4,190,575
123,524 shares
|
— | 30 Jun 2025 |
| Vlad Coric |
3/4/5
Director
|
0%
|
$344,996
10,798 shares
|
— | 13 May 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
484
Shares
327,857,254
Rows loaded
485
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
452
Q3 2025 holders
484
Holder diff
32
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend